Page last updated: 2024-08-24

simendan and Inflammation

simendan has been researched along with Inflammation in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (27.27)	29.6817
2010's	7 (63.64)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Chai, HT; Chen, CH; Chen, YL; Chiang, JY; Sung, PH; Yang, CC; Yip, HK	1
Atasoy, P; Ateş, G; Bakar, B; Büyükkoçak, Ü; Kısa, Ü; Yaman, F	1
Chivite, D; Corbella, X; Formiga, F	1
Aliabadi, A; Buchberger, E; de Martin, R; Demyanets, S; Gröger, M; Hofer-Warbinek, R; Huber, K; Kastl, SP; Kaun, C; Krychtiuk, KA; Maurer, G; Pisoni, J; Rauscher, S; Speidl, WS; Watzke, L; Wojta, J; Zuckermann, A	1
Adam, M; Baldus, S; Costard-Jäckle, A; Klinke, A; Knors, H; Meyer, S; Radunski, UK; Rudolph, TK; Rudolph, V; Spin, JM; Tsao, PS	1
Dekhuijzen, PN; Heunks, LM; Linkels, M; Scheffer, GJ; Schellekens, WJ; van der Hoeven, JG; van Hees, HW	1
Bakirci, EM; Cankaya, M; Capoglu, I; Demirtas, L; Gürbüzel, A; Gürbüzel, M; Sayar, I	1
Auvinen, H; Hämäläinen, M; Kankaanranta, H; Korhonen, R; Moilanen, E; Nissinen, E; Sareila, O	1
Dong, L; Fan, Y; Ji, M; Li, GM; Li, R; Peng, YG; Wu, J; Yang, J	1
Abrass, CK; Hanson, SY; Johnson, AC; Lund, S; Zager, RA	1
Antoniades, C; Karamitros, I; Latsios, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Trikas, A; Vasiliadou, K	1

Reviews

1 review(s) available for simendan and Inflammation

Article	Year
[Organ-protection therapy. A new therapeutic approach for acute heart failure?]. Medicina clinica, 2014, Volume: 142 Suppl 1 Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan	2014

Article

Year

[Organ-protection therapy. A new therapeutic approach for acute heart failure?].

Medicina clinica, 2014, Volume: 142 Suppl 1

Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan

2014

Trials

1 trial(s) available for simendan and Inflammation

Article	Year
Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure. European journal of heart failure, 2006, Volume: 8, Issue:8 Topics: Aged; fas Receptor; Female; Heart Failure; Humans; Hydrazones; Inflammation; Infusions, Parenteral; Interleukin-6; Male; Pyridazines; Receptors, Tumor Necrosis Factor, Type I; Simendan; Solubility; Time Factors; Tumor Necrosis Factor-alpha	2006

Article

Year

Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure.

European journal of heart failure, 2006, Volume: 8, Issue:8

Topics: Aged; fas Receptor; Female; Heart Failure; Humans; Hydrazones; Inflammation; Infusions, Parenteral; Interleukin-6; Male; Pyridazines; Receptors, Tumor Necrosis Factor, Type I; Simendan; Solubility; Time Factors; Tumor Necrosis Factor-alpha

2006

Other Studies

9 other study(ies) available for simendan and Inflammation

Article	Year
Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148 Topics: Aminobutyrates; Animals; Apoptosis; Biphenyl Compounds; Cardio-Renal Syndrome; Cardiovascular Agents; Drug Combinations; Fibrosis; Humans; Inflammation; Kidney; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Simendan; Stroke Volume; Valsartan; Ventricular Function, Left	2022
Evaluation of the systemic antiinflammatory effects of levosimendan in an experimental blunt thoracic trauma model. Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2017, Volume: 23, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Hydrazones; Inflammation; Interleukin-1beta; Pyridazines; Random Allocation; Rats; Rats, Wistar; Simendan; Thoracic Injuries; Wounds, Nonpenetrating	2017
Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro. Thrombosis and haemostasis, 2015, Volume: 113, Issue:2 Topics: Anti-Inflammatory Agents; Cell Adhesion; Cells, Cultured; Decanoic Acids; E-Selectin; Enzyme-Linked Immunosorbent Assay; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Hydrazones; Hydroxy Acids; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Interleukin-8; Microcirculation; Microscopy, Fluorescence; Muscle Cells; Myocardial Infarction; Myocytes, Cardiac; Necrosis; Neutrophils; NF-kappa B; Phosphorylation; Pyridazines; Reactive Oxygen Species; Simendan; Vasodilator Agents	2015
Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure. Scientific reports, 2015, Apr-13, Volume: 5 Topics: Anti-Inflammatory Agents; Biomarkers; Blood Pressure; Cardiotonic Agents; Cell Degranulation; Female; Heart Failure; Humans; Hydrazones; Inflammation; Leukocytes; Male; Middle Aged; Neutrophils; Nitric Oxide; Peroxidase; Pyridazines; Severity of Illness Index; Simendan; Time Factors	2015
Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice. Critical care (London, England), 2015, Mar-02, Volume: 19 Topics: Aldehydes; Animals; Cardiotonic Agents; Chemokines; Diaphragm; Endotoxemia; Hydrazones; Inflammation; Interleukins; Mice, Inbred C57BL; Models, Animal; Nitric Oxide Synthase; Pyridazines; Respiration, Artificial; RNA, Messenger; Simendan	2015
The preventive role of levosimendan against bleomycin-induced pulmonary fibrosis in rats. Pharmacological reports : PR, 2016, Volume: 68, Issue:2 Topics: Animals; Bleomycin; Catalase; Erythrocytes; Glutathione Reductase; Hydrazones; Inflammation; Lung; Male; Phosphogluconate Dehydrogenase; Pulmonary Fibrosis; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan	2016
Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli. British journal of pharmacology, 2008, Volume: 155, Issue:6 Topics: Animals; Cell Line; Fibroblasts; Genes, Reporter; Hydrazones; Inflammation; L Cells; Luciferases; Macrophages; Mice; Molecular Structure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Pyridazines; Simendan; Transcription, Genetic; Transfection	2008
Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock. Inflammation, 2012, Volume: 35, Issue:3 Topics: Animals; Arginine Vasopressin; Blood Pressure; Drug Therapy, Combination; Female; Hemodynamics; HMG-Box Domains; Hydrazones; Inflammation; Interleukin-6; Lactic Acid; Lung; Nitrates; Nitrites; Norepinephrine; Peritonitis; Pulmonary Artery; Pulmonary Gas Exchange; Pyridazines; Random Allocation; Respiratory Physiological Phenomena; Shock, Septic; Simendan; Swine	2012
Levosimendan protects against experimental endotoxemic acute renal failure. American journal of physiology. Renal physiology, 2006, Volume: 290, Issue:6 Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Chemokine CCL2; Endotoxemia; Glyburide; Hydrazones; Inflammation; Ischemia; Kidney; Lipopolysaccharides; Male; Mesangial Cells; Mice; Nitric Oxide; Potassium Channel Blockers; Potassium Channels; Pyridazines; Simendan; Tumor Necrosis Factor-alpha	2006